Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World June 2011	Breaking through the barrier Getting drug molecules into the brain means crossing the defensive blood-brain barrier. Anthony King investigates how chemists are infiltrating the brain's fortress
The Motley Fool December 23, 2011 Brian Orelli	Geron's Hurry-Up-and-Wait Strategy Clinical trials started, now the waiting begins.
Chemistry World March 4, 2011 Elinor Richards	Laser treatment for late-stage cancer Scientists from China, the US and Peru claim to have successfully treated late-stage breast cancer patients using laser immunotherapy to stimulate patients' own immune systems to fight the cancer.
Chemistry World September 5, 2013 Emma Stoye	Raman-based imaging takes guesswork out of brain surgery A new technique that color-codes cancerous and healthy brain cells according to their chemistry could help surgeons remove all traces of brain tumors while minimizing damage to sensitive tissues.
BusinessWeek May 27, 2010 Pettypiece & Gibson	Training the Immune System to Fight Cancer Bristol-Myers' new melanoma drug may be a "game changer."
The Motley Fool May 24, 2010 Brian Orelli	ASCO Abstracts -- Pops and Drops! Ever since The American Society of Clinical Oncology began posting abstracts on-line -- and before that when they were sent to attendees -- investors have clamored to get a glimpse at the data. Here's your glimpse.
The Motley Fool June 6, 2011 Brian Orelli	Big Pharma Tackles Lung Cancer; Biotech Helping, Too A big underserved market.
Chemistry World April 10, 2008 Sarah Houlton	Radiotherapy Side-Effects Suppressed A new drug being developed by scientists at Cleveland BioLabs (CBLI) in the US may hold the key to protecting healthy cells from the effects of radiotherapy during cancer treatment.
Chemistry World June 4, 2008 John Bonner	Fireflies make light work of tumours Cancer researchers can see how effective new chemotherapy drugs are at destroying tumours by using the light that causes fireflies to glow in the dark.
The Motley Fool June 30, 2010 Brian Orelli	When Researchers Attack, Investors Lose Drug investors have to watch out for a lot of things that can change their stock's price: earnings reports, clinical trial results, competitor's results, and FDA decisions.
Chemistry World August 3, 2010 Lewis Brindley	Nanoparticles and ultrasound team up to treat tumors A new, non-invasive method to deliver drugs to the brain has been developed by Taiwanese researchers.
The Motley Fool May 31, 2011 Brian Orelli	5 Biotechs With Upcoming Clinical Trial Results Investors willing to stay in these stocks a little while could see substantial gains well ahead of FDA approvals.
Chemistry World May 11, 2011 Jon Cartwright	New radioisotope bodes well for cancer treatment The isotope, terbium-161, emits a number of low-energy electrons upon decay, which should make it useful for treating small tumors.
Chemistry World November 11, 2015 Maria Burke	Viral cancer therapy approved in the US The first virus therapy to target cancer has been approved in the US. Its main target will be melanoma, the most aggressive form of skin cancer.
Chemistry World March 22, 2009 Sarah Houlton	Integrin inhibitors could promote tumour growth A group of scientists has found that at low doses these drugs might actually have the opposite effect and promote tumor growth.
Chemistry World June 12, 2014 Andy Extance	Pharma vies to unleash immune system power on cancer Drug firms are investing heavily in clinical trials and collaborations as they seek to capitalize on the potential of cancer therapies that enlist or enhance our immune systems' ability to fight tumors.
Chemistry World June 3, 2011 Jennifer Newton	Across the barrier for tumor imaging A probe that can cross the blood-brain barrier to allow high sensitivity brain tumor imaging has been made by Chinese scientists.
Chemistry World June 11, 2015 Sarah Houlton	Companies clamour for CAR-T The biopharmaceutical industry is getting excited about chimeric antigen receptor T-cells, or CAR-T cells, designed to harness the cell-killing power of the immune system.
The Motley Fool June 2, 2011 Luke Timmerman	Infinity Dares to Think Big Against Pancreatic Cancer, Prepares to Show Early Results This Weekend Infinity Pharmaceuticals' top execs sometimes get strange looks when they say they are developing a new drug for pancreatic cancer. Is this a smart use of the company's time and resources?
Chemistry World July 3, 2015 Andy Extance	Pharma queues up for checkpoint inhibitor collaborations Amid fierce rivalries over the latest generation of cancer treatments, drug makers have been weaving a complex web of collaborations on combination therapies spanning much of the pharmaceutical industry.
Chemistry World June 21, 2006 Katharine Sanderson	Peptide Agent Tracks Angiogenesis A molecular imaging agent that can track the progress of tumour growth is about to be trialled by GE Healthcare.
The Motley Fool June 17, 2010 Luke Timmerman	Oncothyreon's Cancer Vaccine Back in the Saddle as Merck KGaA Re-Starts Clinical Trials The German-based Merck got clearance from the FDA and local ethics review boards to resume two of three large pivotal trials.
Chemistry World November 23, 2006 Victoria Gill	Bacteria That Help Fight Cancer Scientists have given a new meaning to the term `friendly bacteria' by discovering a bacterial protein that helps treat cancer.
Chemistry World November 21, 2006 Victoria Gill	Side-Effect-Free Chemotherapy Scientists have now developed an enzyme with the potential to eliminate the extreme fatigue, sickness and hair loss that result from this cell damage and strike fear into the hearts of cancer patients.
The Motley Fool June 6, 2011 Luke Timmerman	Exelixis Zeroes In on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients Is Exelixis' risky bet about to pay off?
Nursing June 2011 Cahill & Armstrong	Caring for an adult with a malignant primary brain tumor Pprimary brain tumors are relatively uncommon, occurring in an estimated 63,000 patients in the united states each year.
Chemistry World August 31, 2011 Hayley Birch	Smallpox vaccine virus puts cancer in its sights The results of a human cancer therapy trial show for the first time that tumors can be targeted and infected by engineered viruses, without damage to surrounding tissues.
Chemistry World July 20, 2011 Josh Howgego	Magnets turn up the heat on tumours Claims that magnets can cure cancer might sound like quackery. But French researchers have harnessed iron oxide structures from bacteria to selectively kill tumour cells using an alternating magnetic field.
Chemistry World July 2010 Anna Lewcock	Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition.
BusinessWeek August 26, 2010 Tom Randall	Cocktails Are Next For Cancer-Drug Makers Taking a cue from the cocktails of drugs that have made AIDS survivable, drugmakers are pursuing combination therapies against cancer.
Pharmaceutical Executive December 1, 2010 Walter Armstrong	Cancer: On Target Once More Over the past year or two, a handful of Phase III failures, including megablockbusters like Avastin and Sutent in trials for all kinds of common tumors, indicate that targeted therapy is generally a blunt instrument.
The Motley Fool March 30, 2010 Brian Orelli	Invest in This Space at Your Own Risk Lung cancer is a tough foe for drugmakers.
The Motley Fool May 28, 2010 Brian Orelli	This Drug Doesn't Work. But All Is Not Lost. Novartis cancer drug fails one trial, but there's still hope.
Pharmaceutical Executive July 1, 2011 Dickmeyer & Rosenbeck	From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition?
The Motley Fool March 25, 2011 Brian Orelli	Pfile Pfizer Under "Potential" Researchers reported promising finding from a clinical trial of Pfizer's new drug, CP-870,893, in pancreatic cancer patients in the most recent issue of the journal Science.
Chemistry World July 22, 2013 Kirsty Muirhead	Circulating cancer cells spiral towards separation A new biochip developed by researchers in Singapore can isolate tumor cells from blood samples, and may one day be an alternative to more invasive methods for tracking later stage cancers.
Scientific American March 2009 Elaine Schattner	A Chip against Cancer: Microfluidics Scrutinizes T Cells With just a blood sample, a device could determine whether cancer is about to spread or monitor the progress of treatment
The Motley Fool June 15, 2010 Brian Orelli	Just Enough to Give Investors Hope Hitting a secondary endpoint means all is not lost for Onyx's lung cancer drug.
Chemistry World March 5, 2008 Lewis Brindley	Arsenic Enhances Cancer Imaging Locating tumors with pin-point accuracy could soon be possible with a new therapy that uses radioactive arsenic.
Chemistry World November 30, 2006 Jessica Ebert	Morning After Pill Might Prevent Breast Cancer The active ingredient of the morning-after pill -- mifepristone, or RU-486 -- prevents the formation of mammary-cell tumours in mice with a mutation in the breast cancer susceptibility gene, BRCA1, report scientists.
Chemistry World January 17, 2011 Laura Howes	Nanoparticle divides to conquer Scientists have made a nanoparticle that breaks up into smaller units once it reaches its target, allowing it to penetrate deeper into tumour tissue and deliver treatment more effectively.
Chemistry World September 18, 2006 Michael Gross	Iron Chelates Beat Cancer Cancer cells need more iron than normal body cells to sustain their abnormally rapid growth. Researchers have now identified one particularly potent chelate complex that helps deplete tumors of iron.
Chemistry World June 2, 2015 Tim Wogan	Simple sensor can spot cancer markers in minutes An electrochemical sensor that can detect specific mutant nucleic acids from cancers in blood samples could allow quick and cheap 'liquid biopsies'.
BusinessWeek September 23, 2010 Rob Waters	Stem Cells That Save Big Pharma a Bundle Drugmakers hope to save big by using stem cells to test drugs for dangerous side effects long before costly human trials are needed.
Chemistry World June 4, 2015 Thadchajini Retneswaran	Microfluidic approach to personalised cancer treatment US scientists have developed an innovative microfluidic assay that can accurately predict how patients with a certain type of blood cancer will respond to an anticancer drug.
Chemistry World September 12, 2013 Paola Quattroni	Brain cancer severity linked with oxidation state of iron New research shows that the higher the malignancy grade of a brain tumor, the higher the iron(ii) to iron(iii) ratio in human brain tissue. The finding could point to new approaches for measuring the malignancy grade of tumors.
Chemistry World November 1, 2006 Victoria Gill	Beta Blockers as Cancer Therapy Researchers have shown how the stress hormone noradrenaline fuels the growth and spread of aggressive, malignant tumours. The data suggest beta blockers, drugs commonly used to treat high blood pressure reverse the effects of noradrenaline.
HHMI Bulletin Aug 2011 Richard Saltus	T-Cell Booster Kits A bioengineer remodels cell surfaces to prod the immune system.
Chemistry World August 27, 2013 Polly Wilson	Hydrogel treatment targets tumors Hydrogels of cancer drug taxol injected directly into tumors have been shown to be more effective at inhibiting tumor growth than intravenous taxol injections of four times the dosage.
The Motley Fool October 27, 2006 Jack Uldrich	Nanotech and the War on Cancer New imaging advances in nanotechnology will help speed cancers' end. What does it mean for investors?